Skip to main content
EXO-CAR • RESEARCH USE ONLY

Cardiac Exosomes

Cardiac exosomes are derived from cardiac progenitor cells and contain cardioprotective and angiogenic factors.

Product image for Cardiac Exosomes
CPC-derived EVs
CARDIAC LINEAGE SOURCE
— Extracellular vesicles from cardiac progenitor cells carrying cardioprotective and angiogenic factors tailored to myocardial stress models.
Neo-vessels · less fibrosis
REPAIR PHENOTYPE
— Promotes angiogenesis, limits fibrotic remodeling, and protects cardiomyocytes from apoptosis after ischemic or structural insults.
HF · post-MI · CAD
INDICATION MAP
— Applications span myocardial infarction, congestive heart failure, ischemic cardiomyopathy, arrhythmia research, and residual coronary disease support.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenousIMIntramuscular
Quantities
400 Billion Exosomes1ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Myocardial Infarction
  • Congestive Heart Failure
  • Ischemic Cardiomyopathy
  • Arrhythmias
  • Cardiac fibrosis reduction
  • Coronary artery disease

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup